$4.30
-0.10[-2.27%]
Last update: 9:07AM Get Real Time Here
Avenue Therapeutics
(NASDAQ:ATXI)Avenue Therapeutics Stock (NASDAQ:ATXI), Quotes and News Summary
Avenue Therapeutics Stock (NASDAQ: ATXI) stock price, news, charts, stock research, profile.
| Open | $4.300 |
| Close | - |
| Volume / Avg. | 27.238K / 57.080K |
| Day Range | 4.170 - 4.370 |
| 52 Wk Range | 4.040 - 93.750 |
| Market Cap | $2.561M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 28 |
| Short Interest | 32.51% |
| Days to Cover | 1 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Avenue Therapeutics (ATXI) stock?
You can purchase shares of Avenue Therapeutics (NASDAQ: ATXI) through any online brokerage.
Who are Avenue Therapeutics's (ATXI) competitors?
Other companies in Avenue Therapeutics’s space includes: Cingulate (NASDAQ:CING), NovaBay Pharmaceuticals (AMEX:NBY), cbdMD (AMEX:YCBD), 60 Degrees (NASDAQ:SXTP) and MyMD Pharmaceuticals (NASDAQ:MYMD).
What is the target price for Avenue Therapeutics (ATXI) stock?
The latest price target for Avenue Therapeutics (NASDAQ: ATXI) was reported by Maxim Group on Monday, December 11, 2023. The analyst firm set a price target for 0.75 expecting ATXI to fall to within 12 months (a possible -82.56% downside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Avenue Therapeutics (ATXI)?
The stock price for Avenue Therapeutics (NASDAQ: ATXI) is $4.3 last updated Today at May 9, 2024 at 9:07 AM EDT.
Does Avenue Therapeutics (ATXI) pay a dividend?
There are no upcoming dividends for Avenue Therapeutics.
When is Avenue Therapeutics (NASDAQ:ATXI) reporting earnings?
Avenue Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.
Is Avenue Therapeutics (ATXI) going to split?
There is no upcoming split for Avenue Therapeutics.
What sector and industry does Avenue Therapeutics (ATXI) operate in?
Avenue Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.